Abbott's CancerGuard Progress Adds New Dimension To Diagnostics Growth Story [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Laboratories, NYSE:ABT, received the AACR Cancer Prevention Research Award for its work in multi cancer early detection. New long term outcomes data from the DETECT A study showed successful early detection and survival outcomes when cancers were treated at earlier stages. The findings reinforce Abbott's multi biomarker testing approach as a potential tool for earlier cancer diagnosis across multiple tumor types. For investors tracking Abbott at a share price of $96.81, this update sits against a challenging share performance backdrop, with the stock showing a 22.0% decline year to date and a 23.9% decline over the past year. Shares are also lower over the past 3 years and 5 years, with returns of 6.9% and 13.2% declines respectively. This keeps attention on what could drive the next phase of growth in the diagnostics franchise. This recognition from a leading cancer research body, together with long term outcomes data, adds a fresh element to the NYSE:ABT story beyond
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (ABT) had its price target lowered by UBS Group AG from $158.00 to $135.00. They now have a "buy" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by Argus from $140.00 to $125.00. They now have a "buy" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by Leerink Partners from $119.00 to $106.00. They now have a "market perform" rating on the stock.MarketBeat
- Abbott Laboratories: Buy The Dip On This Dividend King [Seeking Alpha]Seeking Alpha
- Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- 4/2/26 - Form 4
- ABT's page on the SEC website